title: Reducing the duration of untreated first-episode psychosis: effects on clinical presentation.
abstract: BACKGROUND
  Most studies on first-episode psychosis show an association between a long duration of untreated psychosis (DUP) and poorer short-term outcome, but the mechanisms of this relationship are poorly understood.
  
  
  OBJECTIVE
  To determine whether it is possible to reduce the DUP for first-episode patients in a defined health care area through the introduction of an early detection (ED) program, compared with parallel health care areas without an ED program (No-ED).
  
  
  METHODS
  We included consecutive patients with a DSM-IV diagnosis of nonorganic, nonaffective psychosis coming to their first treatment in the study health care areas between January 1, 1997, and December 31, 2000. A total of 281 patients (76% of the total) gave informed consent.
  
  
  METHODS
  The ED and No-ED health care areas offered an equivalent assessment and treatment program for first-episode psychosis. The ED area also carried out an intensive ED program.
  
  
  RESULTS
  The DUP was significantly shorter for the group of patients coming from the ED area, compared with patients from the No-ED areas (median, 5 weeks [range, 0-1196 weeks] vs 16 weeks [range, 0-966 weeks]). Clinical status measured by the Positive and Negative Syndrome Scale and the Global Assessment of Functioning Scale was significantly better for patients from the ED area at start of treatment and, with the exception of Positive and Negative Syndrome Scale positive subscale, at 3 months. Multiple linear regression analyses gave no indication that confounders were responsible for these differences.
  
  
  CONCLUSIONS
  It is possible to reduce the DUP through an ED program. The reduction in DUP is associated with better clinical status at baseline that is maintained after 3 months.
authors.affiliation: Division of Psychiatry, Ullevaal University Hospital, Oslo, Norway. Ingrid.melle@psykiatri.uio.no
authors.forename: Ingrid
authors.initials: I
authors.lastname: Melle
authors.forename: Tor K
authors.initials: TK
authors.lastname: Larsen
authors.forename: Ulrik
authors.initials: U
authors.lastname: Haahr
authors.forename: Svein
authors.initials: S
authors.lastname: Friis
authors.forename: Jan Olav
authors.initials: JO
authors.lastname: Johannessen
authors.forename: Stein
authors.initials: S
authors.lastname: Opjordsmoen
authors.forename: Erik
authors.initials: E
authors.lastname: Simonsen
authors.forename: Bjørn Rishovd
authors.initials: BR
authors.lastname: Rund
authors.forename: Per
authors.initials: P
authors.lastname: Vaglum
authors.forename: Thomas
authors.initials: T
authors.lastname: McGlashan
mesh_terms: D000328:Adult; D003937:Diagnosis, Differential; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008605:Mental Health Services; D011379:Prognosis; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome